未分類

• 2022/04
  Prof. Horacio Cabral from Red Arrow Therapeutics, Co., Ltd. presented promising preclinical data of RA-001 (pH-sensitive polymeric micelles loading IL-12) at AACR Annual Meeting 2022. RA-001 demonstrated a potent anti-tumor immunity in multiple tumor models. Furthermore, RA-001 showed high efficacy as monotherapy and in combination with immune checkpoint inhibitors.
  
  See Poster Presentation